320TL, Scientist, Protein Chemistry / Molecular Engineering

Job Code 320TL


Fate Therapeutics is currently seeking a talented and motivated individual with expertise in protein chemistry and molecular biology to join a multidisciplinary team dedicated to discovery and productization of novel off-the-shelf cell-based immunotherapies. Initially the candidate will perform production and functional assessment of research-grade recombinant proteins and guide RNAs to support Fate’s gene editing platform and preclinical pipelines. The position will evolve to include establishment of qualified protocols for expression, purification, and analytical assays for protein and RNA batches used in the manufacturing process of genetically engineered induced pluripotent stem cells (iPSCs). Candidate is highly desired to master the entire process of production of recombinant proteins and RNAs and to independently design and deliver high quality results to meet Fate’s aggressive timelines. This is a full-time position that reports to the Director, Molecular Engineering and is located at the company’s corporate headquarters in San Diego.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 320TL.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product candidate pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.